Fresenius Kabi to allot 1550255 Equity Shares on Preferential basis

Fresenius Kabi Oncology Ltd has announced that the Board of Directors of the Company, by way of circular resolution passed on March 20, 2009 has, pursuant to the receipt of shareholder consent, approved the allotment of 1550255 equity shares of Rs 1/- each at a premium of Rs 44.96/- per share on a preferential basis, on receipt of Rs 71,249,719.80/- as the total consideration, to Atlas - Vermoegensverwaltungs-GmbH.

After the aforesaid allotment, public shareholding in the Company stands increased to 10% of the total issued and paid up share capital.

The stock was trading at Rs.35.50, up by Rs.0.15 or 0.42%. The stock hit an intraday high of Rs.35.55 and low of Rs.35.

The total traded quantity was 1705 compared to 2 week average of 2283.

Source : Equity Bulls

Keywords